Market Research Industry Reports

Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2018

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2018

Summary

GlobalDatas clinical trial report, Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2018" provides an overview of Phenylketonuria (PKU) clinical trials scenario. This report provides top line data relating to the clinical trials on Phenylketonuria (PKU). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 and E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 and E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Phenylketonuria (PKU) to Metabolic Disorders Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Phenylketonuria (PKU) to Metabolic Disorders Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Phenylketonuria (PKU) Therapeutics Clinical Trials 25
Prominent Drugs 26
Latest Clinical Trials News on Phenylketonuria (PKU) 27
Apr 30, 2018: Homology Medicines Announces Upcoming Presentations on its Genetic Medicines Platform at the American Society of Gene & Cell Therapy Meeting 27
Mar 12, 2018: Synlogic Presents Preclinical Data on Synthetic Biotic Medicine SYNB1618 at Annual Meeting of The Society for Inherited Metabolic Disorders 27
Clinical Trial Profile Snapshots 28
Appendix 62
Abbreviations 62
Definitions 62
Research Methodology 63
Secondary Research 63
About GlobalData 64
Contact Us 64
Source 64

List Of Tables

List of Tables
Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials by Region, 2018* 6
Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
Phenylketonuria (PKU) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 9
Phenylketonuria (PKU) Therapeutics Clinical Trials, North America, Top Countries, 2018* 10
Phenylketonuria (PKU) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 11
Phenylketonuria (PKU) Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 12
Proportion of Phenylketonuria (PKU) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2018* 13
Phenylketonuria (PKU) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 14
Phenylketonuria (PKU) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 15
Proportion of Phenylketonuria (PKU) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2018* 16
Phenylketonuria (PKU) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 17
Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials by Phase, 2018* 18
Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 19
Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 20
Phenylketonuria (PKU) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 21
Phenylketonuria (PKU) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 22
Phenylketonuria (PKU) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 23
Phenylketonuria (PKU) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 24
Phenylketonuria (PKU) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 25
Phenylketonuria (PKU) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 26

List Of Figures

List of Figures
Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials by Region (%), 2018* 6
Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
Phenylketonuria (PKU) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 9
Phenylketonuria (PKU) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 10
Proportion of Phenylketonuria (PKU) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2018* 13
Phenylketonuria (PKU) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 14
Phenylketonuria (PKU) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 15
Proportion of Phenylketonuria (PKU) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2018* 16
Phenylketonuria (PKU) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 17
Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 18
Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 19
Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 20
Phenylketonuria (PKU) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 21
Phenylketonuria (PKU) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 22
Phenylketonuria (PKU) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 23
Phenylketonuria (PKU) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 24
Phenylketonuria (PKU) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 25
Phenylketonuria (PKU) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 26
GlobalData Methodology 63

Phenylketonuria (PKU) - Pipeline Review, H2 2018

Phenylketonuria (PKU) - Pipeline Review, H2 2018The latest Pharmaceutical and Healthcare disease pipeline guide Phenylketonuria (PKU) - Pipeline Review, H2 2018, provides an overview of the Phenylketonuria (PKU) (Metabolic Disorders)

USD 2000View Report

Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2018

Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2018GlobalDatas clinical trial report, Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2018 provides an overview of Phenylketonuria (PKU) clinical trials scenario. This report

USD 2500View Report

Phenylketonuria (PKU) - Pipeline Review, H2 2018

Phenylketonuria (PKU) - Pipeline Review, H2 2018The latest Pharmaceutical and Healthcare disease pipeline guide Phenylketonuria (PKU) - Pipeline Review, H2 2018, provides an overview of the Phenylketonuria (PKU) (Metabolic Disorders)

USD 2000View Report

Global Phenylketonuria (PKU) Market Research Report 2018

Phenylketonuria (PKU) Report by Material, Application, and Geography Global Forecast to 2022 is a professional and in-depth research report on the worlds major regional market conditions, focusing on the

USD 2850View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 2500
  • Site Licence    USD 5000
  • Enterprise Wide Licence    USD 7500
$ 2500

Reports Details

Published Date : May 2018
No. of Pages :64
Country :Global
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube